The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biologic Therapeutics Drugs-Global Market Insights and Sales Trends 2024
Synopsis
The global Biologic Therapeutics Drugs market size is expected to reach US$ 487360 million by 2029, growing at a CAGR of 6.0% from 2023 to 2029. The market is mainly driven by the significant applications of Biologic Therapeutics Drugs in various end use industries. The expanding demands from the Rheumatoid Arthritis, Anemia, Cancer and Diabetes, are propelling Biologic Therapeutics Drugs market. Avian Cell Culture, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Yeast segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biologic Therapeutics Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biologic Therapeutics Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biologic Therapeutics Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biologic Therapeutics Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biologic Therapeutics Drugs covered in this report include Pfizer, AstraZeneca, Novartis, Merck, Smith Medical, GlaxoSmithKline, Concord Biotech, Aurobindo Pharma and H. Lundbeck, etc.
The global Biologic Therapeutics Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
AstraZeneca
Novartis
Merck
Smith Medical
GlaxoSmithKline
Concord Biotech
Aurobindo Pharma
H. Lundbeck
Retractable Technologies
Global Biologic Therapeutics Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biologic Therapeutics Drugs market, Segment by Type:
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
Global Biologic Therapeutics Drugs market, by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Biologic Therapeutics Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Biologic Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Biologic Therapeutics Drugs market size is expected to reach US$ 487360 million by 2029, growing at a CAGR of 6.0% from 2023 to 2029. The market is mainly driven by the significant applications of Biologic Therapeutics Drugs in various end use industries. The expanding demands from the Rheumatoid Arthritis, Anemia, Cancer and Diabetes, are propelling Biologic Therapeutics Drugs market. Avian Cell Culture, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Yeast segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biologic Therapeutics Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biologic Therapeutics Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biologic Therapeutics Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biologic Therapeutics Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biologic Therapeutics Drugs covered in this report include Pfizer, AstraZeneca, Novartis, Merck, Smith Medical, GlaxoSmithKline, Concord Biotech, Aurobindo Pharma and H. Lundbeck, etc.
The global Biologic Therapeutics Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
AstraZeneca
Novartis
Merck
Smith Medical
GlaxoSmithKline
Concord Biotech
Aurobindo Pharma
H. Lundbeck
Retractable Technologies
Global Biologic Therapeutics Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biologic Therapeutics Drugs market, Segment by Type:
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
Global Biologic Therapeutics Drugs market, by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Biologic Therapeutics Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Biologic Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Biologic Therapeutics Drugs Market Overview
1.1 Biologic Therapeutics Drugs Product Overview
1.2 Biologic Therapeutics Drugs Market Segment by Type
1.2.1 Avian Cell Culture
1.2.2 Yeast
1.2.3 Bacteria
1.2.4 Insects Cell Culture
1.2.5 Transgenics
1.3 Global Biologic Therapeutics Drugs Market Size by Type
1.3.1 Global Biologic Therapeutics Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Biologic Therapeutics Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Biologic Therapeutics Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Biologic Therapeutics Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Biologic Therapeutics Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Biologic Therapeutics Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Biologic Therapeutics Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Biologic Therapeutics Drugs Sales Breakdown by Type (2018-2023)
2 Global Biologic Therapeutics Drugs Market Competition by Company
2.1 Global Top Players by Biologic Therapeutics Drugs Sales (2018-2023)
2.2 Global Top Players by Biologic Therapeutics Drugs Revenue (2018-2023)
2.3 Global Top Players by Biologic Therapeutics Drugs Price (2018-2023)
2.4 Global Top Manufacturers Biologic Therapeutics Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Biologic Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Biologic Therapeutics Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Biologic Therapeutics Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologic Therapeutics Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Biologic Therapeutics Drugs Market
2.8 Key Manufacturers Biologic Therapeutics Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Biologic Therapeutics Drugs Status and Outlook by Region
3.1 Global Biologic Therapeutics Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Biologic Therapeutics Drugs Historic Market Size by Region
3.2.1 Global Biologic Therapeutics Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Biologic Therapeutics Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Biologic Therapeutics Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Biologic Therapeutics Drugs Forecasted Market Size by Region
3.3.1 Global Biologic Therapeutics Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Biologic Therapeutics Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Biologic Therapeutics Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Biologic Therapeutics Drugs by Application
4.1 Biologic Therapeutics Drugs Market Segment by Application
4.1.1 Rheumatoid Arthritis
4.1.2 Anemia
4.1.3 Cancer
4.1.4 Diabetes
4.1.5 Others
4.2 Global Biologic Therapeutics Drugs Market Size by Application
4.2.1 Global Biologic Therapeutics Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Biologic Therapeutics Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Biologic Therapeutics Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Biologic Therapeutics Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Biologic Therapeutics Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Biologic Therapeutics Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Biologic Therapeutics Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Biologic Therapeutics Drugs Sales Breakdown by Application (2018-2023)
5 North America Biologic Therapeutics Drugs by Country
5.1 North America Biologic Therapeutics Drugs Historic Market Size by Country
5.1.1 North America Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Biologic Therapeutics Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Biologic Therapeutics Drugs Sales in Value by Country (2018-2023)
5.2 North America Biologic Therapeutics Drugs Forecasted Market Size by Country
5.2.1 North America Biologic Therapeutics Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Biologic Therapeutics Drugs Sales in Value by Country (2024-2029)
6 Europe Biologic Therapeutics Drugs by Country
6.1 Europe Biologic Therapeutics Drugs Historic Market Size by Country
6.1.1 Europe Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Biologic Therapeutics Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Biologic Therapeutics Drugs Sales in Value by Country (2018-2023)
6.2 Europe Biologic Therapeutics Drugs Forecasted Market Size by Country
6.2.1 Europe Biologic Therapeutics Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Biologic Therapeutics Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Biologic Therapeutics Drugs by Region
7.1 Asia-Pacific Biologic Therapeutics Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Biologic Therapeutics Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Biologic Therapeutics Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Biologic Therapeutics Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Biologic Therapeutics Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Biologic Therapeutics Drugs Sales in Value by Region (2024-2029)
8 Latin America Biologic Therapeutics Drugs by Country
8.1 Latin America Biologic Therapeutics Drugs Historic Market Size by Country
8.1.1 Latin America Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Biologic Therapeutics Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Biologic Therapeutics Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Biologic Therapeutics Drugs Forecasted Market Size by Country
8.2.1 Latin America Biologic Therapeutics Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Biologic Therapeutics Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Biologic Therapeutics Drugs by Country
9.1 Middle East and Africa Biologic Therapeutics Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Biologic Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Biologic Therapeutics Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Biologic Therapeutics Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Biologic Therapeutics Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Biologic Therapeutics Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Biologic Therapeutics Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Biologic Therapeutics Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AstraZeneca Biologic Therapeutics Drugs Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis Biologic Therapeutics Drugs Products Offered
10.3.5 Novartis Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck Biologic Therapeutics Drugs Products Offered
10.4.5 Merck Recent Development
10.5 Smith Medical
10.5.1 Smith Medical Company Information
10.5.2 Smith Medical Introduction and Business Overview
10.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Smith Medical Biologic Therapeutics Drugs Products Offered
10.5.5 Smith Medical Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GlaxoSmithKline Biologic Therapeutics Drugs Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Concord Biotech
10.7.1 Concord Biotech Company Information
10.7.2 Concord Biotech Introduction and Business Overview
10.7.3 Concord Biotech Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Concord Biotech Biologic Therapeutics Drugs Products Offered
10.7.5 Concord Biotech Recent Development
10.8 Aurobindo Pharma
10.8.1 Aurobindo Pharma Company Information
10.8.2 Aurobindo Pharma Introduction and Business Overview
10.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Aurobindo Pharma Biologic Therapeutics Drugs Products Offered
10.8.5 Aurobindo Pharma Recent Development
10.9 H. Lundbeck
10.9.1 H. Lundbeck Company Information
10.9.2 H. Lundbeck Introduction and Business Overview
10.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 H. Lundbeck Biologic Therapeutics Drugs Products Offered
10.9.5 H. Lundbeck Recent Development
10.10 Retractable Technologies
10.10.1 Retractable Technologies Company Information
10.10.2 Retractable Technologies Introduction and Business Overview
10.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Retractable Technologies Biologic Therapeutics Drugs Products Offered
10.10.5 Retractable Technologies Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Biologic Therapeutics Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Biologic Therapeutics Drugs Industrial Chain Analysis
11.4 Biologic Therapeutics Drugs Market Dynamics
11.4.1 Biologic Therapeutics Drugs Industry Trends
11.4.2 Biologic Therapeutics Drugs Market Drivers
11.4.3 Biologic Therapeutics Drugs Market Challenges
11.4.4 Biologic Therapeutics Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Biologic Therapeutics Drugs Distributors
12.3 Biologic Therapeutics Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
